Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites-Reference-Cited by-同舟云学术

Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites

Published:2021-02-01 Issue:7 Volume:116 Page:1437-1446
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Tan Hiang Keat,Teng Margaret Li Peng,Soh Alex Yu Sen,Cheo Sara Hui Yi,Fook-Chong Stephanie,Goh George Boon Bee,Tan Chee Kiat,Wong Guan Wee,Lee Guan Huei,Chang Jason Pik Eu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. The changing epidemiology of liver diseases in the Asia-Pacific Region;Wong;Nat Rev Gastroenterol Hepatol,2019

2. A 20-year prospective study of cirrhosis;Saunders;Br Med J (Clin Res Ed),1981

3. Cryptogenic liver disease in the United States: Further evidence of non-A, non-B and non-C hepatitis;Kodali;Am J Gastroenterol,1994

4. Cryptogenic cirrhosis and NAFLD: Are they related?;Maheshwari;Am J Gastroenterol,2006

5. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease;Caldwell;Hepatology,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis;Journal of Hepatology;2024-06

2. Natural history of metabolic dysfunction-associated steatotic liver disease;European Journal of Internal Medicine;2023-11

3. Impact of catheter tip to hepatic vein ostium distance on the validity and prognostication of hepatic venous pressure gradient in cirrhosis;Scientific Reports;2023-10-09

4. Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-15

5. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event;JHEP Reports;2022-08